Oncolytics Biotech : NOTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERS TO BE HELD ON MAY 15, 2024 MANAGEMENT INFORMATION CIRCULAR - Form 6-K

NOTICE OF ANNUAL GENERAL MEETING


OF SHAREHOLDERS TO BE HELD ON MAY 15, 2024


- AND -


MANAGEMENT INFORMATION CIRCULAR





...

Related Keywords

Germany ,University Of Dayton ,Ohio ,United States ,Louisiana ,Massachusetts ,Guelph ,Ontario ,Canada ,New Jersey ,Munich ,Bayern ,Toronto ,United Kingdom ,Ireland ,Michigan ,Pennsylvania ,Calgary ,Alberta ,New York ,Princeton University ,Irish ,Canadian ,American ,Canadians ,America ,Sanofi Pasteur ,Angela Holtham ,Laurel Hill ,Broadridge Quickvote ,Deborahm Brown ,Thomasc Heineman ,Jamest Parsons ,Aptose Biosciences ,Matthewc Coffey ,Amyg Levin ,Matt Coffey ,Berndr Seizinger ,Bernd Seizinger ,Bristol Myers Squibb ,Patricia Andrews ,Allison Hagerman ,Wayne Pisano ,Revolo Biotherapeutics ,Jonathan Rigby ,Michael Bennett ,James Parsons ,Deborah Brown ,Altimmune Inc ,Global Head Of Clinical Development ,Member Of The Compensation Committee ,National Pharmaceutical Organization ,Glycomimetics Inc ,Member Of The Audit Committee ,United Therapeutics Corporation ,National Instrument ,Laws Of The Corporation ,Broadridge Financial Solutions Inc ,Sheffield University ,Us Exchange ,John Fisher College ,Rotman School Of Management ,Toronto Stock Exchange ,Management Of The Corporation ,Compensation Committee ,Serono ,Common Shares Of The Corporation ,Nasdaq ,Sumitomo Pharma Oncology Inc ,University School Of Business ,Corporation Management ,University Of Guelph ,Amorfix Life Sciences Ltd ,Member Of The Science Development Committee ,Diamedica Therapeutics Inc ,Sumitomo Pharma Co Ltd ,Trillium Therapeutics Inc ,Member Of The Governance Committee ,Exchange Act Rule ,United States Securities Exchange ,Audit Committees Of Sernova Corp ,Governance Committee ,Science Development ,Corporation At Suite ,Articles Of Incorporation The Corporation ,University Of Calgary ,Institute Of Corporate Directors Designation ,Corporation Stock Option Plan ,Oncolytics Biotech Inc ,Bioplus Acquisition Corp ,Trust Company ,Governance Or Science Development Committee ,Pfizer ,Rigby ,Aprea Therapeutics Inc ,Portsmouth University ,Laurel Hill Advisory Group ,Peer Group ,Nabisco Inc ,Corporation Board Of Directors The Peer Group ,Bioinvent International ,Technology Committee ,Steadymed Ltd ,Science Development Committee ,Harvard Medical School ,Zogenix Inc ,Business Development ,Opsona Therapeutics Ltd ,Audit Committee ,Health Care Index ,Brown University ,University Of Toronto ,Sernova Corp ,University Of Michigan ,Honors In Biological Sciences ,Product Development ,Novartis ,Officers Of The Corporation ,Clinical Development ,Aptose Biosciences Inc ,Aon Company Radford ,Number Of Directors The Corporation ,Annual Meeting ,Special Meeting ,Management Information Circular ,Investor Relations ,Management Information ,Chief Executive Officer ,Oncolytics Biotech ,Annual General Meeting ,Registered Shareholder ,Common Shares ,Control Number ,Toronto Time ,North American Toll Free ,Calls Outside North America ,Beneficial Shareholder ,Objecting Beneficial Owners ,Non Objecting Beneficial Owners ,Registered Shareholders ,Beneficial Shareholders ,United States Securities Exchange Act ,Beneficial Owners ,Reporting Issuer ,Notice And Access Provisions ,Canadian Securities Administrators ,Broadridge Financial Solutions ,Vote Your Common ,Common Share ,Record Date ,Financial Statements ,Auditor Report ,Date Appointed ,Principal Occupation ,Preceding Five Years ,Sumitomo Pharma Oncology ,Global Head ,Executive Officer ,Executive Vice President ,Chief Commercial Officer ,Vice President ,General Manager ,Canadian Strategic Partnerships ,Managing Director ,Innovative Medicines Canada ,Western University ,Corporate Directors Designation ,Human Gene Therapy ,Chief Operating Officer ,Chief Scientific Officer ,Chief Financial Officer ,Senior Vice President ,Chief Financial ,Ontario Based Hospital ,Sick Children ,Trillium Therapeutics ,Lorus Therapeutics ,Audit Committees ,Diamedica Therapeutics ,Group Chief Executive Officer ,United Therapeutics ,Profile Therapeutics ,Phillips Medical ,Immunomolecular Therapeutics Board ,Biological Sciences ,Oncology Drug Discovery ,Academic Alliances ,Massachusetts General ,Aprea Therapeutics ,Nykode Therapeutics ,Majority Voting Policy ,Cease Trade Orders ,Chartered Accountants ,Stock Option Plan ,Share Award Plan ,Compensation Framework ,Aon Company ,Named Executive Officer ,Named Executive Officers ,Share Awards ,Erroneously Awarded Incentive Based Compensation ,Exchange Act ,Clawback Policy ,Sarbanes Oxley Act ,Long Term Incentives ,Chief Medical Officer ,Clinical Operations ,Share Award ,Executive Compensation Related Fees ,Compensation Related ,Option Based Awards ,Share Based Awards ,Learned During ,Development Committee ,Stock Option ,Exercise Price ,Eligible Person ,Eligible Persons ,Incentive Share Award Plan ,Vesting Percentage ,Share Awards Agreements ,Cessation Date ,Compensation Plan Information ,Each Employment Agreement ,Employment Agreements ,Cause Severance ,Control Severance ,Continuing Education ,Board Members ,Canadian System ,Electronic Document Analysis ,Board Diversity Policy ,Business Corporations Act ,Corporate Secretary ,America Toll Free ,